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Abstract
The identification of reproductive toxicants is a major scientific challenge for human health. Prenatal life is the most vulnerable and
important time span of human development. For obvious ethical reasons, in vivo models cannot be used in human pregnancy, and
animal models do not perfectly reflect human physiology. This review describes the in vitro test models representative of the
human feto–maternal interface and the effects of environmental chemicals with estrogen-like activity, mainly bisphenol A and
para-nonylphenol, with a particular emphasis on the effects at low, nontoxic doses similar to concentrations commonly detected
in the population.
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The Feto–Maternal Interface: A Complex
Network of Endocrine, Paracrine, and
Autocrine Factors
Human pregnancy is a complex and finely regulated process
during which 2 genetically different organisms, the mother and
the embryo/fetus, establish a very intimate contact.1-3 A huge
number of molecules are secreted at the feto–maternal interface
by both the mother and the embryo/fetus and act on both sides.4
Thus, the mother and the embryo interact via specific tissues in
a reciprocal exchange of molecules that act as communication
signals.
Placentation in human pregnancy involves invasion of the
blastocyst in maternal endometrium up to the spiral arteries.
The trophoblast cells, which surround the blastocyst, first con-
tact the uterine epithelium, then dislodge the endometrial
epithelial cells, and invade the maternal endometrium. During
its journey, the trophoblast follows 2 differentiation path-
ways—the villous and the extravillous ones (Figure 1).5 In the
villous pathway, the mononuclear cytotrophoblast cells form-
ing the internal layer of villi fuse and form the multinucleated
syncytiotrophoblast, which is the epithelial covering of the
chorionic villi (floating villi). In the extravillous pathway, the
cytotrophoblast cells move beyond the overlying syncytium
and form multilayer cell columns of extravillous trophoblast
that fix the villi to the maternal tissues (anchoring villi). These
cells then move deeper into the maternal tissues up to the
proximal third of the myometrium and endometrial spiral
arteries (Figure 1).
Human endometrium has a key role for reproductive effi-
ciency, and its remodeling takes place under the control of
steroid hormones.6,7 This tissue undergoes dramatic cyclic
changes regarding cell proliferation, secretory functions,
regression, and regeneration. Hormonal stimuli lead the mater-
nal tissues to the formation of the decidua at the end of each
cycle. If fertilization has occurred, the blastocyst reaches the
uterine epithelium and implantation starts.
The correct signaling between the decidua and the fetal
trophoblast is of paramount importance for blastocyst implan-
tation and successful pregnancy (Figure 2).2,7
In the complex scenario of the feto–maternal interface,
endocrine, paracrine, and autocrine factors must be taken into
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consideration. Hormones, such as estrogens, progesterone, and
human chorionic gonadotropin (hCG) are the major players of
the endocrine regulation that take place at the feto–maternal
interface. Human chorionic gonadotropin, which is the hor-
mone produced by the trophoblast in the very early stages of
pregnancy, plays a key role in making sure that the endome-
trium is ready to receive the embryo implantation.8 Those
molecules which have an autocrine/paracrine action are impor-
tant factors in the establishment and advancement of preg-
nancy.9 Among these are cytokines including the interleukins
(IL)s IL-1, IL-4, IL-5, IL-6, IL-8, and IL-10, the macrophage
migration inhibitory factor (MIF), colony stimulating factors
(CSFs) and the leukemia inhibiting factor, and different growth
factors (GFs) such as the epidermal GF and the vascular
endothelial GF. All these molecules are potent immunoregula-
tors that play a key role in the feto–maternal tolerance to the
semiallogeneic embryo.10 These molecules are also media-
tors of cell proliferation/differentiation and apoptosis con-
tributing to fetal growth and expansion in the maternal
tissues.11,12 Therefore, their presence at the feto–maternal
interface may modulate the maternal immune response and
contribute to the expansion of fetal tissues in the maternal
uterus.
Prostaglandins (PGs) also play a pivotal role in angiogen-
esis, mitogenesis, cell proliferation, and differentiation and
exert an important role during the early stages of
pregnancy.7,13,14
Environmental Contaminants: A Threat for
Human Reproductive Health
There are increasing data that support the adverse effects on
human reproductive health caused by environmental contami-
nants, especially endocrine-disrupting chemicals. These chemi-
cals are man-made or plant-derived compounds that can bind to
the receptors of steroid hormones and thus impair hormone-
driven physiological functions in female and male reproductive
system.15,16 Among these, diethylstilbestrol (DES), a nonster-
oidal estrogenic compound, has been commercialized as ther-
apeutic for reproductive disorders. Regrettably, only after its
commercialization its deleterious effects became evident.
Among industrial compounds is bisphenol A (BPA), a polymer
that can be released by polycarbonated plastics and by the
linings of metal cans that are used for food and beverages.17,18
Consequently, BPA can be easily absorbed via the food
chain,19 and indeed it can be easily detected in the human body.
With regard to pregnancy, levels of BPA have been detected in
the placenta, fetal liver, in the blood, and in the follicular fluid
in a range of 0.3-40 nmol/L.18,20,21 Bisphenol A shares many
similarities with the endogenous estrogens22 and acts on
estrogen-responsive organs by binding to estrogen receptor
(ER) isoforms, ERa and ERb.23,24 The estrogenic activity of
BPA has been demonstrated in Ishikawa cells, an endometrial
cell line.6 Bisphenol A also binds to the progesterone receptors
(PRs) and thus exert antiprogestin activity.25,26 Furthermore,
BPA is able to mimic glucocorticoids, another class of steroid
hormones fundamental at the feto–maternal interface. Bisphe-
nol A is indeed able to bind with the mineralocorticoid and
glucocorticoid receptors (GRs).27,28 Interestingly, it has been
demonstrated that environmental concentrations of BPA (10
nmol/L) increased the messenger RNA (mRNA) expression
and enzymatic activity of the enzyme 11b-hydroxysteroid
dehydrogenase type 1 in the adipose tissue and the visceral
adipocytes isolated from children.29 Furthermore, perinatal
exposure to BPA resulted in a decreased expression of GR in
the brain of female rats compared to controls.30 This environ-
mental chemical was listed as reference compound within the
European ReProTect Programme because of its well-known
reproductive toxicity.31,32 Another environmental chemical
derived from the manufacturing industry is para-nonylphenol
(p-NP), an alkylphenol applied as a plasticizer and surfactant,
known to have estrogenic activity since 1991.33 Human
Figure 2. The interplay of endocrine and paracrine mediators at the
feto–maternal interface. hCG indicates human chorionic gonadotro-
pin; GFs, growth factors; PGs, prostaglandins.
Figure 1. Villous and extravillous trophoblast in human placentation.
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exposure to p-NP may occur by cutaneous absorption, inges-
tion of contaminated food or water, and inhalation.34,35 Estro-
genic activity of p-NP has been known since 199133 and
reported in a number of in vitro36 and in vivo studies.37 Inter-
estingly, studies in rats showed that maternal exposure to p-NP
resulted in an increase in uterine calbinding-D 9k (CaBP-9k)
mRNA and protein expression in maternal and neonatal uteri,
suggesting its potential transfer through the placenta.38,39
CaBP-9k is a cytosolic calcium-binding protein expressed in
various tissues (eg, intestine, uterus, and placenta) and a marker
of estrogenic compounds exposure.40
Since the number of man-made chemicals released in the
environment have been growing exponentially in the last
decades,41 the assessment of the risks that derive from the
exposure to chemicals is of paramount importance.31
Risks Assessment of Intrauterine Exposure
Because of their ability to interfere with steroid hormones and
their widespread distribution in everyday products, many of the
chemicals in the environment represent a hazard to the repro-
ductive system of adult women. Much greater concern arises
when we take into account prenatal exposure to these bioactive
compounds. Prenatal life is indeed the most critical phase of
the life cycle, as it is the period in which organs and tissues are
formed.42
Already during the periimplantation period, the intrauterine
environment is able to provoke epigenetical changes that will
persist later in life.43 Barker and coworkers initiated the inves-
tigation of the developmental origins of many diseases that
appear in later life.44 Then many researchers followed, reveal-
ing a dramatic scenario in which alterations in the intrauterine
environment can result in pathologies and dysfunctions in
adulthood.45
For many decades, the human placenta has been considered
a protective organ. It was assumed that the placenta interdicted
the passage of harmful compounds to the fetus. However, the
placenta has not been adapted to act as a barrier to the many
substances that have been produced by man in the last decades.
Therefore, the human placenta might not be able to prevent
fetal exposure to these potentially dangerous compounds.
Indeed, due to their high lipophilicity, many environmental
estrogens are able to elude the placental barrier and potentially
harm the fetus.46 Moreover, the placenta is a highly sensitive
tissue to environmental contaminants with estrogenic activity
as it expresses both ERa and ERb.47 Since the placenta is the
fundamental organ to maintain pregnancy and assure fetal
development and growth, it seems to be extremely important
to estimate the risk of exposure during in utero life by evaluat-
ing the effects of these contaminants on the placenta and the
uterus. Animal models remain a solid and important shield to
study human pregnancy establishment and development, but,
unfortunately, they often fail to completely reproduce the com-
plexity of human reproduction. Many efforts have been taken
in order to shed light on the physiological, pathological, and
toxicological aspects of human pregnancy, and in vitro models
represent a valid help for researchers in this field.
In this report, we will mainly focus on BPA and p-NP as
representative chemicals with estrogen-like activity. Special
emphasis will be put on the effects at low doses that are rele-
vant with or are lower than those found in the environment and
in human tissues. In fact, it is important to underline that envi-
ronmental chemicals with estrogenic activity can have different
effects at different doses.6 In particular, some of these com-
pounds have their detrimental effects at very low concentra-
tions while higher concentrations are not effective in the same
way.48-50
In vitro Models of Human Placenta
Many efforts have been made to develop in vitro models for
studies of the placenta. It is indeed important to emphasize that
animal placenta does not model the human placenta and its
physiology well. As human placenta is, in fact, an organ that
varies from one species to another, therefore the use of animals
could not be appropriate to study the mechanisms that take
place during human pregnancy. Moreover, for obvious ethical
reasons, studies on human placenta can be performed only in
tissues and cells obtained from the organ after its delivery.
Thus, in vitro models need to be developed to investigate pla-
centa establishment and development in the maternal uterus as
well as to identify factors influencing these physiological pro-
cesses. These models mainly include trophoblast cells and
cultures of placenta villous explants.
Freshly isolated cytotrophoblast cells can be obtained by
enzymatic dissociation of villous placental tissue, followed
by Percoll gradient separation. These cells are able to differ-
entiate into multinucleated syncytiotrophoblast cells when cul-
tured in complete medium. However, they do not proliferate in
vitro and thus cannot be cultured for a long time.51,52 For these
reasons, many immortalized and carcinoma-derived cell lines
(BeWo, JAr, JEG-3, and HTR-8/SVneo) have been set up to
study selected aspects of the human placenta in vitro.53 For
example, the human trophoblast cell lines BeWo and HTR-8/
SVneo cells are representative of specific differentiation path-
ways of trophoblast during placentation (Figure 3). In particu-
lar, the choriocarcinoma-derived BeWo cell line is
representative of the villous pathway since it reveals most of
the characteristics of the villous syncytiotrophoblast including
cell fusion54 and secretion of hormones such as the b-hCG.55
The HTR-8/SVneo cells are representative of the invasive
extravillous trophoblast, specifically of those cells which, after
detaching from the chorionic villi, migrate to and infiltrate into
the maternal decidua. These cells are originated from human
first-trimester human placenta and in vitro immortalized by
transfection with a complementary DNA construct that encodes
the simian virus 40 large T antigen.56 Based on the cells’ spe-
cific characteristics, any toxic effect observed on BeWo cells
may forecast impairment of placenta growth, while any effect
toward HTR-8/SVneo cells may contribute to an unsatisfactory
blastocyst implantation and placentation in vivo.
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However, despite the high reproducibility of the experi-
ments provided by these cell lines, the results obtained can
be far from the in vivo situation. Furthermore, cell lines enable
the study of a single cell type at a time, while the human
placenta consists of many cell types. Some ex vivo models
offer the opportunity to maintain all the main placental cell
types in the same culture.57,58
A suitable in vitro model more closely resembling the in
vivo pattern of trophoblast differentiation is offered by primary
cultures of placenta explants from fresh human placenta.57 This
model includes dissection of terminal villi from human placen-
tal tissues (Figure 4). A variety of culture conditions can be
used to reproduce in utero environments at different times of
gestation. Usually, explants from placental tissues at first-
trimester pregnancy are cultured on a bed of Matrigel which
the tissues adhere to and then expand, mimicking placenta
establishment and its development in the maternal uterus.
Explants from term placenta are usually cultured on the bottom
of the well or as free-floating villi, hanging on a supporting
device. This type of culture mainly reflects the syncytialization
of the villous trophoblast.57
The model of placental explants presents several advan-
tages: First, unlike in the one with isolated cells, this model
preserves the topology of intact villi including all the main fetal
cell types in the chorionic villi, for example, the syncytio- and
the cytotrophoblast, the villous stromal, and endothelial cells,
thus preserving each mechanism of paracrine regulation. Sec-
ond, this model mimics the trophoblast functions more realis-
tically, including production and release of secretory
components, proliferation, growth, and differentiation. Third,
placental explants can be set up with tissues from early and
term placenta, making it possible to compare the effects of
substances both at early and term pregnancy. The main disad-
vantage of this model is its inability to distinguish among the
functional roles of the various cell types present in this organ.
Overall, the model of placental explants allows to study all
aspects of placental biochemistry and molecular biology char-
acterizing the physiological processes during the organ devel-
opment, pharmacology, toxicology, and disease processes.
Other in vitro models of human placenta have been set up to
study placental transfer.58 Some of these models exemplify the
transfer across a single cell layer while others retain all the
components of the placental barrier, the syncytiotrophoblast,
the cytotrophoblast, the basal membrane, and the endothelial
layer.32 Among the last type of models, the placental perfusion
technique can be found. Thanks to the particular anatomy of the
human placenta which consists of many circulatory units (coty-
ledons; Figure 5), a single cotyledon can be isolated and
perfused.59
Potential Biomarkers in Human Placenta
The human placenta is an exquisite tool to study the effect of
environmental chemicals on human reproduction, due to the
key role of this organ in maintaining pregnancy and providing
fetal health. Toxicity of chemicals needs to be tested in order to
identify concentrations suitable for evaluating potentially dele-
terious effects in the functional processes of the placenta.
Indeed, it is important to separate the effects of toxic doses
from the ones that nontoxic doses might have on a biological
system. To do so, in vitro models can be tested for cell viability
and tissue damage in a wide range of chemical concentrations.
All the immortalized and carcinoma-derived cell lines are eas-
ily cultured and propagated in vitro, and they are generally used
for large-scale screening of many chemicals and/or the effects
of their concentrations.
Once the curve of toxicity is obtained, functional studies can
be conducted using nontoxic doses. Furthermore, in order to
make these studies closer to the in vivo situation, concentra-
tions of chemicals similar to those detected in the human body
should be privileged. As reported in the literature, BPA levels
in human pregnancy ranged from 0.3 and 40 nmol/L in adult
and fetal serum, follicular and amniotic fluid, and pla-
centa.18,20,21 The p-NP levels ranged from 0.1 nmol/L in cord
blood and 1 nmol/L in maternal plasma and blood.60-62
Among the trophoblast cell types, BeWo and HTR-8/SVneo
cells are suitable to detect the specific effects of chemicals with
estrogenic activity in human placenta since both of them
express ERs.63,64 Moreover, given their different differentia-
tion pathways, these cells can be monitored for different
biomarkers. Specifically, BeWo cells can be tested for the
secretion of b-hCG and tissue expression of cleaved caspase-
3, specific markers of endocrine activity of the syncytiotropho-
blast and its apoptotic shedding, respectively.62,65 The HTR-8/
SVneo cells can be monitored by assaying the passage of these
cells through a layer of collagen (cell migration) or matrigel
(cell invasion) as well as by the release of metalloprotease
(MMP)-2 and MMP-9, the most studied MMPs for trophoblast
invasion.66 The use of 2 different cell lines representative of the
main differentiation pathways in human placenta provides
information about the effect of chemicals in the whole process
of placentation.
Figure 3. Specific differentiation pathways of the BeWo and the HTR-
8/SVneo trophoblast cells.
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In the last decade, several studies of BPA and p-NP in in
vitro models of human placenta have been conducted. Studies
in BeWo and HTR-8/SVneo cells showed that these chemicals
caused a decrease in cell viability in the concentration range of
1 mmol/L and 1 mmol/L. Surprisingly, low concentrations
(pmol/L-nmol/L), not affecting cell viability, impaired func-
tional markers of placentation. More specifically, both chemi-
cals, p-NP and BPA, appeared to affect syncytialization of
trophoblast as they both altered hCG secretion and cell apop-
tosis in BeWo cells.32,47 Interestingly, the effect of estrogen-
like chemicals, at low nontoxic concentrations, resulted in a
change in hCG release with an hormetic or biphasic behavior.67
The chemicals studied were indeed stimulating or inhibiting
hCG release depending on their concentration.67 More recent
evidence in HTR-8/SVneo cells showed that cell migration and
invasion were also reduced by BPA and p-NP.50 For each
chemical, the activity was higher at lower concentrations with
a maximum activity between 0.1 and 10 pmol/L. Coculture
studies of HTR-8/SVneo with human umbilical cord endothe-
lial cells (HUVECs) revealed that trophoblast/endothelial inter-
action was significantly reduced by p-NP at 10 pmol/L.
All together, the above-mentioned studies on trophoblast
cells indicate that low concentrations of the environmental
chemicals BPA and p-NP are able to affect the main differen-
tiation pathways of trophoblast, the villous, and extravillous
ones.
It is noteworthy that effective concentrations of p-NP in
hCG secretion were lower in BeWo cells (0.1-1 pmol/L) than
in placental explants (1 nmol/L).47,48 This discrepancy can be
explained by a different pharmacokinetic behavior in the 2
different models probably due to a more complex organization
in a tissue culture with respect to a cell monolayer.
Placental explants give the chance to monitor, with a closer
look into the physiological situation, trophoblast differentiation
both into syncytiotrophoblast and extravillous trophoblast. This
model is also informative about the endocrine secretory activity
of placenta (ie, secretion of hCG, placental lactogen, cytokines,
GFs, and other paracrine/autocrine molecules produced by the
placenta).47,48 In particular, cytokines such as granulocyte
macrophage-CSF (GM-CSF), interferon g (IFN-g), IL-1b, IL-
4, and IL-10 were all increased by pmol/L to nmol/L p-NP with
a maximum effect at 10 pmol/L, which was statistically signif-
icant for GM-CSF and IL-10.47,48 Bisphenol A (1 nmol/L) was
increasing the secretion of the cytokine MIF while BPA levels
ranging from 0.2 to 2 nmol/L, increased tumor necrosis factor-
a gene expression, and protein secretion.49,68
Figure 4. Dissection and culture of placental explants. Representative villous explants culture from 9 weeks’ gestation. Fresh placenta is
dissected and each villous fragment (15-20 mg wet weight) is placed in a 24-well culture plates (Ø 15.6 mm) previously coated with Matrigel.
Villous pieces are then covered with a proper medium and cultured under different experimental conditions. Bar ¼ 3 mm.
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Perfusion experiments on human placenta are a wonderful
tool to investigate the transfer of substances. This model showed
the transfer of BPA across the placenta.32 Furthermore, placental
perfusion can be used to study the placental metabolism of many
chemicals and drugs, the role of transporters as well as the
effects of acute toxicity in placenta (for detailed review, see
Myllynen and Va¨ha¨kangas,58 and Myllynen et al studies69).
The effects of representative substances such as BPA and
p-NP, in the scenario of environmental contaminants, raise
great concern for the environmental risk to the health of the
fetus. Even though they do not cause termination of pregnancy,
low concentrations of these substances could produce anoma-
lies in the functional processes of the placenta, leading to pos-
sible disorders and/or abnormalities later on in pregnancy. For
example, higher levels of cytokines such as MIF in the mater-
nal serum and increased levels of hCG in the second trimester
of pregnancy, have been associated with preeclampsia, a seri-
ous syndrome of human pregnancy.70-73
In vitro Models of Human Endometrium
The human endometrium is a fertility-determining tissue. It
consists of various cell types. Epithelial cells and glandular-
epithelial cells are located in the lining of the uterine lumen.
Stromal, endothelial, and immune cells are mainly located in
endometrial stroma. The cell types that reside in the endome-
trium result to be more sensitive to steroid hormones compared
to the cell types of other tissues.31,74 This raises concern about
the possible deleterious effects of hormone-mimicking com-
pounds on the cycling and pregnant human endometrium.16,75
Primary cells from human endometrium can be easily cul-
tured and are able to proliferate in vitro.76 These primary cul-
tures of endometrial cells respond to hormonal stimuli but,
unfortunately, tend to dedifferentiate after several passages and
therefore cannot be cultured for long periods.77,78 Immortalized
and carcinoma-derived cell lines, such as Ishikawa cells
(derived from epithelial endometrial cells) and St-T1b
(derived from stromal endometrial cells), are also avail-
able.6,78,79 These cell lines are easily cultured and maintained
for long periods, but they often lose responsiveness to hormo-
nal stimuli and this can lead to misleading results. In vitro
models of human endometrial epithelium are used to study
blastocyst attachment and generally to focus on the very first
steps of pregnancy establishment. Cell models of endometrial
stroma are a powerful tool to study trophoblast invasion in the
maternal uterus. Furthermore, such models are often used to
study endometrial pathologies such as endometriosis.80
Endothelial stromal cells can also be used to investigate the
physiological and pathological mechanisms that take place in
the human endometrium. Unfortunately, primary endothelial
cells from human endometrium tend to lose their hormonal
responsiveness after few passages.74 Nevertheless, endothe-
lial cells of uterine origin are far more sensitive to hormonal
stimuli than endothelial cells from other tissues, that is,
HUVECs, and thus tissue-specificity should be always con-
sidered when selecting an in vitro model.74 Models of tissue
explants from human endometrium have been also used.81-83
These can be obtained from the decidual fragments remaining
in the human placenta after elective termination of pregnancy
or after delivery at term.
Figure 5. Anatomy of human placenta. A, Fetal side: the amnion, umbilical cord, and fetal vessels are visible. B, Maternal side: the cotyledons and
their circulatory units are visible. Images by Chiara Mannelli.
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More recently, three-dimensional (3D) models of human
endometrium have been established and are gaining increasing
interest since these models are closer to the in vivo situation.
Indeed, endometrial cells show different features when grown
in 3D matrices compared to cell monolayers.76,77,84
Potential Biomarkers in Human
Endometrium
Among the available in vitro models of human endometrium,
cultures of endometrial cell lines are the most commonly used
in reproductive toxicology. As reported above about the studies
of placenta, toxicity tests are needed to provide guidance for
the range of concentrations suitable for functional testing in
human endometrial physiology. In order to achieve this, viabi-
lity and cell proliferation assays, together with assays of tissue
damage (ie, such as lactate dehydrogenase measurement), are
recommended. Cell lines, such as Ishikawa cells, are a power-
ful tool for screening the effects of environmental chemicals on
the human endometrium.6,85,86 Using these cells, Schaefer and
co-workers6 provided very interesting data on the effects that
DES, BPA, and p-NP can have on endometrial receptivity,
which is a key step for establishment of pregnancy. What is
more, these authors investigated the effects of these substances
in a wide range of concentrations, thus unraveling the dose–
response effects of these chemicals on the endometrium.6
Transfected Ishikawa cells also provided interesting insights
into the estrogen-like activity of many environmental pollu-
tants, such as DES, BPA, genistein, and o-p0-dichlorodiphenyl-
trichloroethane by monitoring the effect of these chemicals on
the activation of estrogen response elements.86
In vitro models of endometrial epithelial cells provide
important insights into the effects of exogenous compounds
on the binding surface that allows blastocyst attachment.
Indeed, the expression of important surface molecules, such
as integrins and osteopontin, after exposure to environmental
chemicals, could represent a very good marker in order to
assess the effect of chemicals on uterine preparation to blasto-
cyst attachment. Many studies proved that the expression of
such molecules is hormone sensitive and can be altered by
exogenous hormone-mimicking compounds in vivo.87-89
On the other hand, endometrial stromal cells are useful to
study the intimate mechanisms that prepare the uterus for a
gestation and that could be disrupted by hormone-mimicking
compounds. Primary cultures of endometrial stromal cells
proved to be an effective tool to study the potential deleterious
effects of BPA.49,90,91 For this purpose, the expression of hor-
mone receptors, that is, ERs, PRs, hCG/luteinizing hormone
receptor, together with the secretion of paracrine/autocrine fac-
tors (ie, cytokines, PGs, and GFs) can be considered a powerful
approach to assess the effect of environmental chemicals on the
stromal compartment of the endometrium. Many authors inves-
tigated the effects of dietary relevant, low doses of phytoestro-
gens, such as genistein and daidzein, on endometrial fibroblasts
by assessing the ability of these compounds to inhibit aroma-
tase activity or cell proliferation.92,93
Cultures of endometrial endothelial cells are useful to study
the specific angiogenetic processes that take place in the uter-
ine environment. The potentially negative effects of BPA or
genistein on the endometrium have been tested on primary
cultures of endothelial cells by checking cell viability, cell
proliferation, and angiogenic activity via the tube-formation
assay.94,95
Furthermore, endometrial coculture systems have been used
to investigate the effects of phytoestrogens on the important
interactions between epithelial and stromal cells, such as ER
activation and cell proliferation.96 Endometrial explants are a
natural coculture system of endometrial cells, which could be
used for reproductive toxicology studies, even if they are, at the
moment, applied mostly for physiological studies.97,98
Coculture Models of Feto–Maternal Interface
Coculture models including cells and/or tissues representative
of both the fetus and the maternal counterpart have been devel-
oped.76,81-83 Many of these focus on the mechanisms of blas-
tocyst implantation. Usually, human blastocyst is mimicked by
spheroids of placental cells76,77 that are allowed to attach to
monolayer cultures of endometrial cells or 3D matrices.
Other coculture models allow the study of a wider spectrum
of interactions at the feto–maternal interface.81-83 Such
approaches mainly focus on the invasion of human placenta
inside the maternal decidua. To mimic this situation, ex vivo
explants of human placenta and decidua have been uti-
lized.81,82,99 These coculture models are a powerful tool as they
include all the main cell types involved at the feto–maternal
interface. They nevertheless require synchronization of pri-
mary cultures from tissues which are sometimes difficult to
obtain. In order to overcome these limitations, Mannelli and
co-workers49 recently applied an in vitro system that could be
helpful to study the molecular interactions at the feto–maternal
interface even in laboratories that do not have availability of
fresh tissues. Indeed, in their article, the authors presented an in
vitro model in which explants of chorionic villi were exposed
to an endometrial stromal cell-conditioned medium collected in
another laboratory.49 Such encouraging approach could widen
the possibilities of different research groups across the world,
and many similar efforts have been taken in the last years.
Indeed, Huppertz and co-workers100 developed the method of
cryogenic preservation of placental explants in order to over-
come the paucity of this tissue in other laboratories.
Potential Biomarkers in Coculture Models of
Feto–Maternal Interface
Coculture models of feto–maternal interface could represent a
useful end point of toxicological studies, in which the effects of
chemicals are tested under more complex and physiological
conditions. These models have been largely used to investigate
physiological processes of pregnancy76,81-83 while only little
has been reported for toxicological studies. Using the model of
endometrial stromal cell-conditioned medium and placental
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explants, Mannelli and co-workers49 demonstrated that the
maternal compartment is able to protect the placenta from the
effects of BPA. The study indeed showed that direct exposure
of placental explant cultures with very low BPA concentrations
(0.5-1 nmol/L) triggered the secretion of MIF and b-hCG and
that these effects were abolished/diminished in the placental
cultures exposed to cell-conditioned medium from endome-
trial stromal cells pretreated with BPA. Although the exact
mechanism/s of maternal protection are not known, the data
highlight the importance of in vitro models reproducing the
complex interactions between the mother and the fetus to
verify the effect of environmental chemicals in pregnancy.
What is more, the choice to use very low concentrations of
BPA revealed how concentrations in the range of 1 nmol/L are
able to trigger a significant physiological unbalance in repro-
ductive tissues.49
Concluding Remarks
Although not fully respecting the in vivo situation, in vitro
models are informative about the effect of chemicals at the
maternal–fetal interface and can give fruitful insights about the
possible correlations between environmental pollutants and
reproductive disorders. However, given the dynamic and com-
plex mechanisms responsible for blastocyst implantation and
placenta development in the maternal uterus, it is difficult to
classify chemically induced alterations as adverse or nonad-
verse effects. One can only state that chemicals that are widely
distributed in the environment and present in daily used prod-
ucts such as BPA and p-NP have the potential to interfere with
the physiological processes of preparation of pregnancy and
placentation. What raises great concern is that chemical con-
centrations lower than those causing cell death can alter fun-
damental biological processes such as uterine receptivity and
placenta development. This might indicate that maternal con-
tamination with these types of chemicals, at concentrations
that do not cause termination of pregnancy, may cause dys-
function in pregnancy and fetal development. Moreover, as
prenatal life is a critical period of life in which the body is
formed and develops, any abnormality in its development will
have negative consequences for adult life. This review aimed
to give an exhaustive overview of all the in vitro models
available and of their current use. Our hope is that more com-
plex models will be applied to studies of environmental tox-
icology, and that the use of low concentrations of chemicals in
toxicological tests will become of common use. Indeed, due to
the limitations of in vitro models, it is important to prepare an
experimental design that is as close as possible to the in vivo
situation. The different dose–response effects and the tissue-
specific effects of chemicals should be always considered as
well.6,91
In conclusion, the data reported here raise great concern for
the environmental risk to pregnancy, indicating the need to
develop more accurate tests for the protection of both the pre-
natal life and the development of the fetus.
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